FTC reportedly may scrutinize Boston Scientific's Axonics deal – MassDevice

Bloomberg reports that the U.S. Federal Trade Commission (FTC) may look into the $3.7 billion acquisition of Axonics by Boston Scientific.

Do you trust this headline?

Based on recent headline ratings, 91% of this readership currently trusts the local media, which has an average score of 73% regionally and is currently trending positive.


Media Trust Score91%